Long‐term (52‐week) efficacy and safety of dapagliflozin as an adjunct to insulin therapy in Japanese patients with type 1 diabetes: Subgroup analysis of the DEPICT‐2 study

AIM: To examine the long‐term efficacy and safety of dapagliflozin, a sodium‐glucose co‐transporter‐2 (SGLT2) inhibitor used to treat type 1 diabetes, in the Japanese subpopulation of the DEPICT‐2 study. MATERIALS AND METHODS: Patients with type 1 diabetes were randomized to dapagliflozin 5 mg (n =...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Obes Metab
Main Authors: Araki, Eiichi, Mathieu, Chantal, Shiraiwa, Toshihiko, Maeda, Hajime, Ikeda, Hiroki, Thoren, Fredrik, Arya, Niki, Asano, Michiko, Iqbal, Nayyar
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2021
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8251623/
https://ncbi.nlm.nih.gov/pubmed/33620762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14362
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados